Țară: Regatul Unit
Limbă: engleză
Sursă: VMD (Veterinary Medicines Directorate)
Sulfadiazine, Trimethoprim
Listow Limited
QJ01EW10
Sulfadiazine, Trimethoprim
Expired
Revised: October 2012 AN: 00752/2012 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Co Trimazine Tablets 480 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains ACTIVE SUBSTANCE(S): MG : Trimethoprim 80 Sulfadiazine 400 EXCIPIENTS: For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet. A circular, uncoated, white tablet scored on one face. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES When susceptible organisms are present the Tablets may be effective in treating the following conditions: alimentary tract infections, respiratory and urogenital infections, skin and wound infections and eye and ear infections. 4.3 CONTRAINDICATIONS Co-trimazine Tablets 480 mg are not suitable for use in cats. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special warnings. Revised: October 2012 AN: 00752/2012 Page 2 of 4 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Use of the product should be based on susceptibility testing of bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Take care to avoid skin contact. Wash hands after use. Sulphonamides may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to sulphonamides may lead to cross reaction with other antibiotics. Allergic reactions to these substances may occasionally be serious. 1. Do not handle this product if you know you are sensitive to sulphonamides. 2. If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the doctor this warning. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) A low incidence of polyarthropathy and Keratoconjunctivitis Sicca (Dry Eye) has b Citiți documentul complet